No headlines found.
AM Best Affirms Credit Ratings of CNO Financial Group, Inc. and Its Life/Health Subsidiaries
Business Wire (Wed, 8-Apr 2:58 PM ET)
PRNewswire (Wed, 4-Mar 9:15 AM ET)
PRNewswire (Mon, 23-Feb 9:15 AM ET)
Retirement Confidence Among Middle-Income Americans Declines Amid Economic Uncertainty
PRNewswire (Wed, 18-Feb 9:15 AM ET)
CNO Financial Group Declares $0.17 Quarterly Dividend and Announces Virtual Annual Meeting Date
PRNewswire (Wed, 11-Feb 4:15 PM ET)
CNO Financial Group Reports Fourth Quarter and Full Year 2025 Results
PRNewswire (Thu, 5-Feb 4:15 PM ET)
CNO Financial Group Announces Senior Leadership Promotions
PRNewswire (Wed, 21-Jan 5:00 PM ET)
CNO Financial Group to Release Fourth Quarter and Full Year 2025 Results on February 5, 2026
PRNewswire (Tue, 20-Jan 4:15 PM ET)
CNO Financial Group Appoints Linda Gibson to its Board of Directors
PRNewswire (Thu, 15-Jan 5:00 PM ET)
CNO Financial Group Inc is a holding company for a group of insurance companies that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
Cno Finl Group trades on the NYSE stock market under the symbol CNO.
As of April 9, 2026, CNO stock price declined to $42.11 with 712,259 million shares trading.
CNO has a beta of 0.78, meaning it tends to be less sensitive to market movements. CNO has a correlation of 0.30 to the broad based SPY ETF.
CNO has a market cap of $3.95 billion. This is considered a Mid Cap stock.
Last quarter Cno Finl Group reported $1 billion in Revenue and $1.47 earnings per share. This beat revenue expectation by $153 million and exceeded earnings estimates by $.27.
In the last 3 years, CNO traded as high as $44.86 and as low as $19.95.
The top ETF exchange traded funds that CNO belongs to (by Net Assets): IJH, AVUV, VTI, IWM, VB.
CNO has underperformed the market in the last year with a return of +18.5%, while the SPY ETF gained +38.4%. In the last 3 month period, CNO fell short of the market, returning -3.7%, while SPY returned -1.1%. However, in the most recent 2 weeks CNO has outperformed the stock market by returning +3.7%, while SPY returned +3.5%.
CNO support price is $42.06 and resistance is $43.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNO shares will trade within this expected range on the day.